Boston Scientific (BSX) financial statements

+140.2%since 2007
FY2025 revenue
$20.1B▲ +19.9%
FY2025 net income
$2.9B▲ +56.7%
FY2025 diluted EPS
$1.94▲ +55.2%
FY2025 free cash flow
$3.7B▲ +38.3%

Boston Scientific income statement

Boston Scientific income statement
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Revenue20,07416,74714,240
Gross profit13,85411,4909,896
Operating income3,6132,6032,343
Pretax income3,3852,2821,985
Net income2,8921,8461,592
Diluted earnings per share1.941.251.07

Boston Scientific balance sheet

Boston Scientific balance sheet
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Cash and cash equivalents1,965606865
Total assets43,67339,39535,136
Total liabilities (derived)19,20117,39215,606
Total equity24,47222,00319,530
Long-term debt11,1378,9688,571

Boston Scientific cash flow statement

Boston Scientific cash flow statement
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Operating cash flow4,5343,4352,503
Capital expenditure-876-790-711
Free cash flow (derived)3,6582,6451,792
Dividends paidn/a0-28

Quarterly highlights

Quarterly highlights
USD millionsQ3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025
Period ended30 Sep 202630 Jun 202631 Mar 202631 Dec 2025
Revenue (derived)5,1385,4425,2035,286
Operating income (derived)8281,1781,101825
Net income (derived)5809051,339670
Diluted earnings per share0.400.610.90n/a
Operating cash flow (derived)1,0481,4743481,364
Total assets45,46145,21644,35143,673

Boston Scientific major shareholders

Boston Scientific major shareholders
HolderShare of classSharesFiled
BlackRock, Inc.7.6%113,006,67117 April 2025
Vanguard Capital Management7.5%111,127,20530 April 2026

Boston Scientific 10-K and SEC filings

Boston Scientific 10-K and SEC filings
FiledFormTypeDescription
2 November 202610-QQuarterly reportQuarterly report
28 October 20268-KCurrent reportCurrent report
7 October 20268-KCurrent reportCurrent report
23 September 20268-KCurrent reportCurrent report
8 September 20268-KCurrent reportCurrent report
26 August 20268-KCurrent reportCurrent report
3 August 202610-QQuarterly reportQuarterly report
29 July 20268-KCurrent reportCurrent report

Common questions

What was Boston Scientific's revenue in fiscal 2025?

Boston Scientific reported $20.1 billion in revenue for fiscal 2025, the year ended 31 December 2025, up 19.9% from fiscal 2024.

What was Boston Scientific's net income in fiscal 2025?

Boston Scientific reported net income of $2.9 billion for fiscal 2025, the year ended 31 December 2025, up 56.7% from fiscal 2024. Diluted earnings per share were $1.94.

What was Boston Scientific's free cash flow in fiscal 2025?

Boston Scientific had $3.7 billion in free cash flow in fiscal 2025. Operating cash flow was $4.5 billion and capital expenditure was $876 million.

What were Boston Scientific's total assets at the end of fiscal 2025?

Boston Scientific reported total assets of $43.7 billion at the end of fiscal 2025, the year ended 31 December 2025.

How much Boston Scientific history does each plan include?

Free covers the last 3 fiscal years of annual figures. Basic covers the last 10 fiscal years, annual and quarterly. Pro covers the full history, with first reported values and as of dates.